CVE-2024-11245
Published: 15 November 2024
Summary
CVE-2024-11245 is a medium-severity Injection (CWE-74) vulnerability in Anisha Farmacia. Its CVSS base score is 5.3 (Medium).
Operationally, exploitation aligns with the MITRE ATT&CK technique Exploit Public-Facing Application (T1190); ranked at the 30.2th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-33702
Vulnerability details
A vulnerability, which was classified as critical, has been found in code-projects Farmacia 1.0. This issue affects some unknown processing of the file /editar-produto.php. The manipulation of the argument id leads to sql injection. The attack may be initiated remotely.…
more
The exploit has been disclosed to the public and may be used.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise TechniquesAI
Why these techniques?
SQL injection in public-facing web application (/editar-produto.php) enables T1190 (Exploit Public-Facing Application) for initial access/execution and T1505 (Server Software Component) for arbitrary SQL command execution, as mapped by VulDB advisory.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing uses SQL injection payloads against database interfaces, identifying and supporting fixes for SQL injection weaknesses.
Developer assessments and testing (including injection-focused techniques) identify improper neutralization of special elements, and the verifiable flaw remediation corrects them pre-deployment.
Validates query inputs to prevent SQL syntax or command manipulation.
Identifies indicators of injection attacks (command, SQL, LDAP, etc.) via anomaly and attack monitoring.